David Linetsky - Jul 1, 2020 Form 4/A - Amendment Insider Report for Phreesia, Inc. (PHR)

Role
SVP, Life Sciences
Signature
/s/ Allison Hoffman by Power of Attorney for David Linetsky
Stock symbol
PHR
Transactions as of
Jul 1, 2020
Transactions value $
$0
Form type
4/A - Amendment
Date filed
9/10/2021, 05:16 PM
Date Of Original Report
Jul 6, 2020
Previous filing
Sep 10, 2021
Next filing
Sep 10, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHR Stock Options (Right to buy) Options Exercise $0 -1.38K -4.2% $0.00 31.4K Jul 1, 2020 Common Stock 1.38K $4.71 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 25% of this option vested and became exercisable on August 7, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
F3 The original Form 4, filed on July 6, 2020, is being amended by this Form 4 amendment to correct the vesting schedule of this grant.
F4 The original Form 4, filed on July 6, 2020, is being amended by this Form 4 amendment to correct the number of derivative securities beneficially owned by the Reporting Person after the reported transaction.